- Home
- VGI vs MBOT Comparison
VGI vs MBOT Comparison
Compare VGI & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VGI | MBOT |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.8M | 73.2M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | VGI | MBOT |
|---|---|---|
| Price | $6.69 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 55.0K | ★ 861.4K |
| Earning Date | 01-01-0001 | 11-24-2026 |
| Dividend Yield | ★ 12.66% | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $377.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.48 | $0.93 |
| 52 Week High | $8.04 | $2.86 |
Technical Indicators
Market Signals| Indicator | VGI | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 39.89 |
| Support Level | $6.51 | N/A |
| Resistance Level | $7.59 | $1.18 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 26.10 | 10.54 |
Price Performance
Historical ComparisonAbout VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.